| Literature DB >> 27155148 |
Yen-Ning Huang1, Ching-I Lin2, Hsiang Liao3, Chin-Yu Liu4, Yue-Hua Chen3, Wan-Chun Chiu3, Shyh-Hsiang Lin5.
Abstract
Epidemiological investigations have shown that Alzheimer's disease (AD) is one of the most common neurodegenerative diseases. It has been indicated that the cholesterol concentration in the brain of AD patients is higher than that in normal people. In this study, we investigated the effects of cholesterol concentrations, 0, as the control, 3.125, 12.5, and 25μM, on cholesterol metabolism, neuron survival, AD-related protein expressions, and cell morphology and apoptosis using SH-SY5Y human neuroblastoma cells. We observed that expressions of cholesterol hydroxylase (Cyp46), flotillin-2 (a marker of lipid raft content), and truncated tyrosine kinase B (TrkBtc) increased, while expressions of brain-derived neurotrophic factor (BDNF) and full-length TrkB (TrkBfl) decreased as the concentration of cholesterol loading increased. Down-regulation of the PI3K-Akt-glycogen synthase kinase (GSK)-3β cascade and cell apoptosis were also observed at higher concentrations of cholesterol, along with elevated levels of β-amyloid (Aβ), β-secretase (BACE), and reactive oxygen species (ROS). In conclusion, we found that cholesterol overload in neuronal cells imbalanced the cholesterol homeostasis and increased the protein expressions causing cell apoptosis, which illustrates the neurodegenerative pathology of abnormally elevated cholesterol concentrations found in AD patients.Entities:
Keywords: 24-OHC; Alzheimer’s disease; BDNF; Cyp46; PI3K-Akt-GSK-3β; lipid raft
Mesh:
Substances:
Year: 2016 PMID: 27155148 DOI: 10.1016/j.neuroscience.2016.04.043
Source DB: PubMed Journal: Neuroscience ISSN: 0306-4522 Impact factor: 3.590